collection
MENU ▼
Read by QxMD icon Read
search

Novellus Aesthetics

shared collection
36 papers 0 to 25 followers Papers and research useful to aesthetics practice
https://www.readbyqxmd.com/read/22091799/clinical-efficacy-of-home-use-blue-light-therapy-for-mild-to-moderate-acne
#1
RANDOMIZED CONTROLLED TRIAL
Michael H Gold, Whitney Sensing, Julie A Biron
INTRODUCTION: Blue-light light-emitting diode (LED) therapy has become widely used for the treatment of inflammatory acne. In this study we evaluated the efficacy of a home use blue-light LED application in improving lesions and shortening their time to clearance. METHODS: This was an IRB approved randomized self-control study. For each patient (n = 30), 2 similar lesions, one of each side of the face were chosen for treatment with either a blue-light LED hand-held or sham device...
December 2011: Journal of Cosmetic and Laser Therapy: Official Publication of the European Society for Laser Dermatology
https://www.readbyqxmd.com/read/26304759/facial-rejuvenation-starts-in-the-midface-three-dimensional-volumetric-facial-rejuvenation-has-beneficial-effects-on-nontreated-neighboring-esthetic-units
#2
REVIEW
Uwe Wollina
Facial aging is a major indication for minimal invasive esthetic procedures. Dermal fillers are a cornerstone in the approach for facial sculpturing. But where to start? Our concept is midfacial volume restoration in first place. This will result in a healthy and youthful appearance creating a facial V-shape. But midfacial filler injection does not only improve the malar area. It has also beneficial effects on neighboring esthetic units. We report on such improvements in periocular and nasolabial region, upper lips and perioral tissue, and the jaw line and discuss anatomical background...
March 2016: Journal of Cosmetic Dermatology
https://www.readbyqxmd.com/read/26313675/aesthetic-policy-and-procedure-protocols-a-must-have-for-every-aesthetic-medical-provider
#3
Connie Brennan
Treatment guidelines are a crucial part of every medical aesthetic practice and must be in place before utilizing aesthetic medical injectables. An "Aesthetic Policy and Procedure Manual" features specific details (e.g., patient assessment, indication, contraindications, warnings and precautions, injection techniques, documentation, etc.) around dermal fillers (e.g., Restylane, Juvéderm, Voluma), hyaluronidase, neurotoxins (e.g., Botox Cosmetic, Dysport, and Xeomin) and Sculptra. This article describes why an "Aesthetic Policy and Procedure" manual is a necessary tool in every aesthetic provider's armamentarium, what it is composed of, as well as how these guidelines serve as a protective mechanism for the aesthetic provider's clinic if legal action is brought against their staff, their medical director, and/or their clinic...
July 2015: Plastic Surgical Nursing
https://www.readbyqxmd.com/read/26362110/the-effect-of-oral-collagen-peptide-supplementation-on-skin-moisture-and-the-dermal-collagen-network-evidence-from-an-ex-vivo-model-and-randomized-placebo-controlled-clinical-trials
#4
RANDOMIZED CONTROLLED TRIAL
Jérome Asserin, Elian Lati, Toshiaki Shioya, Janne Prawitt
BACKGROUND: Skin dryness and an accelerated fragmentation of the collagen network in the dermis are hallmarks of skin aging. Nutrition is a key factor influencing skin health and consequently its appearance. A wide range of dietary supplements is offered to improve skin health. Collagen peptides are used as a bioactive ingredient in nutricosmetic products and have been shown in preclinical studies to improve skin barrier function, to induce the synthesis of collagen and hyaluronic acid, and to promote fibroblast growth and migration...
December 2015: Journal of Cosmetic Dermatology
https://www.readbyqxmd.com/read/26561784/dietary-supplementation-with-specific-collagen-peptides-has-a-body-mass-index-dependent-beneficial-effect-on-cellulite-morphology
#5
RANDOMIZED CONTROLLED TRIAL
Michael Schunck, Vivian Zague, Steffen Oesser, Ehrhardt Proksch
In this double-blind, placebo-controlled clinical study, we investigated the efficacy of specific bioactive collagen peptides (BCP) on the cellulite treatment of normal and overweight women. In total, 105 women aged 24-50 years with moderate cellulite were randomized to orally receive a daily dosage of 2.5 g BCP or a placebo over 6 months. The degree of cellulite was evaluated before starting the treatment and after 3 and 6 months of intake. In addition, skin waviness, dermal density, and the length of subcutaneous borderline were assessed...
December 2015: Journal of Medicinal Food
https://www.readbyqxmd.com/read/26840887/ingestion-of-bioactive-collagen-hydrolysates-enhance-facial-skin-moisture-and-elasticity-and-reduce-facial-ageing-signs-in-a-randomised-double-blind-placebo-controlled-clinical-study
#6
Naoki Inoue, Fumihito Sugihara, Xuemin Wang
BACKGROUND: Several human studies have demonstrated occurrence of two major collagen peptides, prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine (Hyp-Gly), in human peripheral blood. Some in vitro studies have demonstrated that Pro-Hyp and Hyp-Gly exert chemotaxis on dermal fibroblasts and enhance cell proliferation. Additionally, Pro-Hyp enhances the production of hyaluronic acid by dermal fibroblasts. These findings suggest that the amounts of Pro-Hyp and Hyp-Gly in blood are important factors to show the efficacy of collagen hydrolysates on skin health...
September 2016: Journal of the Science of Food and Agriculture
https://www.readbyqxmd.com/read/26904164/skin-antiageing-and-systemic-redox-effects-of-supplementation-with-marine-collagen-peptides-and-plant-derived-antioxidants-a-single-blind-case-control-clinical-study
#7
Chiara De Luca, Elena V Mikhal'chik, Maxim V Suprun, Michael Papacharalambous, Arseniy I Truhanov, Liudmila G Korkina
Recently, development and research of nutraceuticals based on marine collagen peptides (MCPs) have been growing due to their high homology with human collagens, safety, bioavailability through gut, and numerous bioactivities. The major concern regarding safety of MCPs intake relates to increased risk of oxidative stress connected with collagen synthesis (likewise in fibrosis) and to ROS production by MCPs-stimulated phagocytes. In this clinical-laboratory study, fish skin MCPs combined with plant-derived skin-targeting antioxidants (AO) (coenzyme Q10 + grape-skin extract + luteolin + selenium) were administered to volunteers (n = 41)...
2016: Oxidative Medicine and Cellular Longevity
https://www.readbyqxmd.com/read/26404377/botulinum-toxin-type-a-as-a-therapeutic-agent-against-headache-and-related-disorders
#8
REVIEW
Siro Luvisetto, Parisa Gazerani, Carlo Cianchetti, Flaminia Pavone
Botulinum neurotoxin A (BoNT/A) is a toxin produced by the naturally-occurring Clostridium botulinum that causes botulism. The potential of BoNT/A as a useful medical intervention was discovered by scientists developing a vaccine to protect against botulism. They found that, when injected into a muscle, BoNT/A causes a flaccid paralysis. Following this discovery, BoNT/A has been used for many years in the treatment of conditions of pathological muscle hyperactivity, like dystonias and spasticities. In parallel, the toxin has become a "glamour" drug due to its power to ward off facial wrinkles, particularly frontal, due to the activity of the mimic muscles...
September 2015: Toxins
https://www.readbyqxmd.com/read/25807336/male-aesthetics
#9
REVIEW
Terrence Keaney
Men are a fast growing segment of the aesthetic industry. A review was performed for publications on gender differences in facial anatomy, behavior, and the use of minimally invasive aesthetic procedures in men. There are substantial facial anatomical differences between genders with men having a larger but unique cranial shape, increased skeletal muscle mass, unique subcutaneous fat distribution, and more severe facial rhytides. Men also exhibit poor behavior that can accelerate aging including poor utilization of preventive health care services, higher rates of smoking, and increased ultraviolet light exposure...
March 2015: Skin Therapy Letter
https://www.readbyqxmd.com/read/20487038/onabotulinumtoxina-for-treatment-of-chronic-migraine-pooled-results-from-the-double-blind-randomized-placebo-controlled-phases-of-the-preempt-clinical-program
#10
RANDOMIZED CONTROLLED TRIAL
David W Dodick, Catherine C Turkel, Ronald E DeGryse, Sheena K Aurora, Stephen D Silberstein, Richard B Lipton, Hans-Christoph Diener, Mitchell F Brin
OBJECTIVE: To assess the efficacy, safety, and tolerability of onabotulinumtoxinA (BOTOX) as headache prophylaxis in adults with chronic migraine. BACKGROUND: Chronic migraine is a prevalent, disabling, and undertreated neurological disorder. Few preventive treatments have been investigated and none is specifically indicated for chronic migraine. METHODS: The 2 multicenter, pivotal trials in the PREEMPT: Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy clinical program each included a 24-week randomized, double-blind phase followed by a 32-week open-label phase (ClinicalTrials...
June 2010: Headache
https://www.readbyqxmd.com/read/21883197/onabotulinumtoxina-for-treatment-of-chronic-migraine-pooled-analyses-of-the-56-week-preempt-clinical-program
#11
RANDOMIZED CONTROLLED TRIAL
Sheena K Aurora, Paul Winner, Marshall C Freeman, Egilius L Spierings, Jessica O Heiring, Ronald E DeGryse, Amanda M VanDenburgh, Marissa E Nolan, Catherine C Turkel
OBJECTIVE: To evaluate safety and efficacy of onabotulinumtoxinA (BOTOX(®) ) as headache prophylaxis in adults with chronic migraine. BACKGROUND: Chronic migraine is a prevalent, disabling, and undertreated neurological disorder. OnabotulinumtoxinA is the only approved prophylactic therapy in this highly disabled patient population. DESIGN AND METHODS: Two phase III, 24-week, double-blind, parallel-group, placebo-controlled studies, followed by a 32-week, open-label, single-treatment, onabotulinumtoxinA phase, were conducted (January 23, 2006 to August 11, 2008)...
October 2011: Headache
https://www.readbyqxmd.com/read/21956721/onabotulinumtoxina-improves-quality-of-life-and-reduces-impact-of-chronic-migraine
#12
RANDOMIZED CONTROLLED TRIAL
R B Lipton, S F Varon, B Grosberg, P J McAllister, F Freitag, S K Aurora, D W Dodick, S D Silberstein, H C Diener, R E DeGryse, M E Nolan, C C Turkel
OBJECTIVE: To assess the effects of treatment with onabotulinumtoxinA (Botox, Allergan, Inc., Irvine, CA) on health-related quality of life (HRQoL) and headache impact in adults with chronic migraine (CM). METHODS: The Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical program (PREEMPT 1 and 2) included a 24-week, double-blind phase (2 12-week cycles) followed by a 32-week, open-label phase (3 cycles). Thirty-one injections of 5U each (155 U of onabotulinumtoxinA or placebo) were administered to fixed sites...
October 11, 2011: Neurology
https://www.readbyqxmd.com/read/22468643/onabotulinumtoxina-botox%C3%A2-a-review-of-its-use-in-the-prophylaxis-of-headaches-in-adults-with-chronic-migraine
#13
REVIEW
James E Frampton
This article reviews the pharmacology, therapeutic efficacy and tolerability profile of intramuscularly injected onabotulinumtoxinA (onaBoNTA; BOTOX®) for headache prophylaxis in adults with chronic migraine, with a focus on UK labelling for the drug. The pharmacological actions of onaBoNTA include a direct antinociceptive (analgesic) effect; while not fully understood, the mechanism of action underlying its headache prophylaxis effect in chronic migraine is presumed to involve inhibition of peripheral and central sensitization in trigeminovascular neurones...
April 16, 2012: Drugs
https://www.readbyqxmd.com/read/25178393/prospective-analysis-of-the-use-of-onabotulinumtoxina-botox-in-the-treatment-of-chronic-migraine-real-life-data-in-254-patients-from-hull-u-k
#14
Modar Khalil, Hassan W Zafar, Victoria Quarshie, Fayyaz Ahmed
BACKGROUND: Chronic migraine affects 2% of the population. It results in substantial disability and reduced quality of life. Medications used for prophylaxis in episodic migraine may also work in chronic migraine. The efficacy and safety of OnabotulinumtoxinA (BOTOX) in adults with chronic migraine was confirmed in the PREEMPT programme. However, there are few real-life data of its use. METHOD: 254 adults with chronic migraine were injected with OnabotulinumtoxinA BOTOX as per PREEMPT Protocol between July 2010 and May 2013, their headache data were collected using the Hull headache diary and analysed to look for headache, migraine days decrements, crystal clear days increment in the month post treatment, we looked at the 50% responder rate as well...
September 1, 2014: Journal of Headache and Pain
https://www.readbyqxmd.com/read/24107267/onabotulinumtoxina-for-chronic-migraine-efficacy-safety-and-tolerability-in-patients-who-received-all-five-treatment-cycles-in-the-preempt-clinical-program
#15
RANDOMIZED CONTROLLED TRIAL
S K Aurora, D W Dodick, H-C Diener, R E DeGryse, C C Turkel, R B Lipton, S D Silberstein
OBJECTIVE: Chronic migraine (CM) is a prevalent and disabling neurological disorder. Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical program assessed efficacy and safety of onabotulinumtoxinA (BOTOX(®)) for prophylaxis of headaches in adults with CM. This secondary analysis assessed patients who received all five treatment cycles and completed the study. MATERIALS AND METHODS: PREEMPT (two phase III studies: 24-week double-blind, placebo-controlled [DBPC], parallel-group phase, followed by 32-week open-label [OL] phase) evaluated the efficacy and safety of onabotulinumtoxinA in CM (≥15 days/month with headache lasting ≥4 h a day)...
January 2014: Acta Neurologica Scandinavica
https://www.readbyqxmd.com/read/23589955/botulinum-toxin-a-and-headache-treatment
#16
REVIEW
Jacob Gady, Elie M Ferneini
PURPOSE: To determine whether botulinum toxin type A (BOTOX ) is effective for the prophylactic treatment of headaches in adults. MATERIALS AND METHODS: A retrospective literature reviewwas performed. The outcome of various studies is discussed, including whether a decrease in the intensity as well as the occurrence of tension and migraine headaches was accomplished. RESULTS: The approval for botulinum toxin A for the treatment of migraine was based largely on the results of Allergan's PREEMPT Phase III trial...
March 2013: Connecticut Medicine
https://www.readbyqxmd.com/read/22784019/onabotulinumtoxina-botox%C3%A2-a-guide-to-its-use-in-preventing-headaches-in-adults-with-chronic-migraine
#17
Katherine A Lyseng-Williamson, James E Frampton
Intramuscular onabotulinumtoxinA (onaBoNTA; BOTOX®) is indicated for headache prophylaxis in adults with chronic migraine. According to pooled results from two large trials, treatment with up to five cycles of onaBoNTA (155-195 units/cycle) at 12-week intervals was effective in reducing headache symptoms, decreasing headache-related disability and improving health-related quality of life in patients with chronic migraine. OnaBoNTA was generally well tolerated in these trials, with an adverse event profile that was consistent with that of the neurotoxin when injected into head and neck muscles...
August 1, 2012: CNS Drugs
https://www.readbyqxmd.com/read/25355551/a-typical-pattern-of-the-labial-arteries-with-implication-for-lip-augmentation-with-injectable-fillers
#18
Tanvaa Tansatit, Prawit Apinuntrum, Thavorn Phetudom
BACKGROUND: Anatomical knowledge of the vascular supply to the upper- and lower-lip vermilion is essential for lip augmentation. METHODS: The soft tissues of the whole face, including arterial latex injection, were peeled off as a facial flap and turned down for dissection. The mucosal flap was elevated away from the orbicularis oris muscle and the lower facial musculature. The superior and inferior labial arteries were traced from the facial artery along the course of the vermilion...
December 2014: Aesthetic Plastic Surgery
https://www.readbyqxmd.com/read/22148008/can-platelet-rich-plasma-be-used-for-skin-rejuvenation-evaluation-of-effects-of-platelet-rich-plasma-on-human-dermal-fibroblast
#19
Dae Hun Kim, Young Jin Je, Chang Deok Kim, Young Ho Lee, Young Joon Seo, Jeung Hoon Lee, Young Lee
BACKGROUND: Autologous platelet-rich plasma has attracted attention in various medical fields recently, including orthopedic, plastic, and dental surgeries and dermatology for its wound healing ability. Further, it has been used clinically in mesotherapy for skin rejuvenation. OBJECTIVE: In this study, the effects of activated platelet-rich plasma (aPRP) and activated platelet-poor plasma (aPPP) have been investigated on the remodelling of the extracellular matrix, a process that requires activation of dermal fibroblasts, which is essential for rejuvenation of aged skin...
November 2011: Annals of Dermatology
https://www.readbyqxmd.com/read/23949208/oral-supplementation-of-specific-collagen-peptides-has-beneficial-effects-on-human-skin-physiology-a-double-blind-placebo-controlled-study
#20
RANDOMIZED CONTROLLED TRIAL
E Proksch, D Segger, J Degwert, M Schunck, V Zague, S Oesser
Various dietary supplements are claimed to have cutaneous anti-aging properties; however, there are a limited number of research studies supporting these claims. The objective of this research was to study the effectiveness of collagen hydrolysate (CH) composed of specific collagen peptides on skin biophysical parameters related to cutaneous aging. In this double-blind, placebo-controlled trial, 69 women aged 35-55 years were randomized to receive 2.5 g or 5.0 g of CH or placebo once daily for 8 weeks, with 23 subjects being allocated to each treatment group...
2014: Skin Pharmacology and Physiology
label_collection
label_collection
2090
1
2
2014-10-20 16:38:41
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"